Skip to Content
COVID-19 Response and Update

We make healthy possible


A growing portfolio for India patients

We entered the India market in late 2022 and are excited to help write a new chapter in providing innovative, high-quality Specialty medicines for Indian patients and families. Today, we’re making healthy possible through our hospital injectables as well as growing portfolios of ophthalmic and oncology medicines.

Our Portfolio


Offering the gold standard in quality medicines

Since 2008, we’ve been producing medicines for the U.S. market – a global leader and the gold standard in pharmaceutical quality. Today we’re bringing that same Amneal quality commitment to India patients and families. Why? We recognize patient lives depend on it and believe you deserve the best, highest quality medicines.